Syndax Pharmaceuticals, Inc. (SNDX)
9.54
+0.17
(+1.81%)
USD |
NASDAQ |
Nov 06, 16:00
9.79
+0.25
(+2.62%)
After-Hours: 20:00
Syndax Pharmaceuticals EPS Diluted (TTM) : -2.367 for Sept. 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -2.367 |
| June 30, 2026 | -2.518 |
| March 31, 2026 | -2.795 |
| December 31, 2025 | -3.296 |
| September 30, 2025 | -3.615 |
| June 30, 2025 | -3.899 |
| March 31, 2025 | -3.865 |
| December 31, 2024 | -3.730 |
| September 30, 2024 | -3.632 |
| June 30, 2024 | -3.379 |
| March 31, 2024 | -3.222 |
| December 31, 2023 | -2.964 |
| September 30, 2023 | -2.585 |
| June 30, 2023 | -2.437 |
| March 31, 2023 | -2.421 |
| December 31, 2022 | -2.458 |
| September 30, 2022 | 0.0054 |
| June 30, 2022 | 0.1917 |
| March 31, 2022 | 0.3723 |
| December 31, 2021 | 0.4642 |
| September 30, 2021 | -1.823 |
| June 30, 2021 | -1.888 |
| March 31, 2021 | -1.865 |
| December 31, 2020 | -1.884 |
| September 30, 2020 | -1.883 |
| Date | Value |
|---|---|
| June 30, 2020 | -1.826 |
| March 31, 2020 | -1.878 |
| December 31, 2019 | -1.849 |
| September 30, 2019 | -2.110 |
| June 30, 2019 | -2.385 |
| March 31, 2019 | -2.653 |
| December 31, 2018 | -2.914 |
| September 30, 2018 | -3.011 |
| June 30, 2018 | -3.01 |
| March 31, 2018 | -2.97 |
| December 31, 2017 | -2.89 |
| September 30, 2017 | -2.68 |
| June 30, 2017 | -2.84 |
| March 31, 2017 | -2.61 |
| December 31, 2016 | -4.75 |
| September 30, 2016 | -153.79 |
| June 30, 2016 | -152.95 |
| March 31, 2016 | -152.52 |
| September 30, 2014 | -149.70 |
| June 30, 2014 | -0.07 |
| March 31, 2014 | -0.10 |
| December 31, 2013 | -0.06 |
| September 30, 2013 | -0.03 |
| March 31, 2013 | -0.03 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.105 |
| Emergent BioSolutions, Inc. | -5.097 |
| Incyte Corp. | 1.879 |
| Vertex Pharmaceuticals, Inc. | 15.55 |
| Travere Therapeutics, Inc. | -1.659 |